Literature DB >> 21393967

Position paper on mesotherapy.

Rashmi Sarkar1, Vijay Kumar Garg, Venkataram Mysore.   

Abstract

Mesotherapy is a controversial cosmetic procedure which has received publicity among the lay people, in the internet and in the media. It refers to minimally invasive techniques which consist of the use of intra- or subcutaneous injections containing liquid mixture of compounds (pharmaceutical and homeopathic medications, plant extracts, vitamins and other ingredients) to treat local medical and cosmetic conditions. This position paper has examined the available evidence and finds that acceptable scientific evidence for its effectiveness and safety is lacking. IADVL taskforce, therefore would like to state that the use of this technique remains controversial at present. Further research and well-designed controlled scientific studies are required to substantiate the claims of benefit of this mode of therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21393967     DOI: 10.4103/0378-6323.77479

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

1.  [Side effects in aesthetic medicine. Spectrum, management and avoidance].

Authors:  U Wollina; A Goldman; C Naoum
Journal:  Hautarzt       Date:  2013-03       Impact factor: 0.751

2.  Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy.

Authors:  Massimo Mammucari; Antonio Gatti; Sergio Maggiori; Alessandro F Sabato
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

3.  Optimal Solubility of Diclofenac β-Cyclodextrin in Combination with Local Anaesthetics for Mesotherapy Applications.

Authors:  Giuseppe Tringali; Pierluigi Navarra
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-10       Impact factor: 2.629

Review 4.  Mesotherapy in the treatment of musculoskeletal pain in rehabilitation: the state of the art.

Authors:  T Paolucci; R G Bellomo; M A Centra; N Giannandrea; L Pezzi; R Saggini
Journal:  J Pain Res       Date:  2019-07-30       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.